Evaluating the Effectiveness of Repricing for Market Expansion in the Japanese Drug Pricing System

Therapeutic Innovation & Regulatory Science
Shoyo ShibataTakeshi Suzuki

Abstract

In 1994, the "Repricing for Market Expansion" system (the repricing system) was introduced to the pharmaceutical market in Japan to improve the financial performance of the national health insurance system. In 2010, the "Reward Premiums for the Promotion of Innovative Drug Discovery and the Resolution of Off-Label Use Issue, Etc." system (the reward system) was introduced to promote the development of new drugs. This study evaluates the effectiveness of these systems from an empirical perspective. The data set used in this study was created using publicly available information from the Ministry of Health, Labour and Welfare (MHLW) website and a market database maintained by IMS Japan Pharmaceutical Market Sales. Anticancer or immunomodulating drugs were the most frequently affected by the repricing system. The sales of similar drugs did not exceed double the sales forecast, and to begin with, the repricing system was not applied to these drugs, unintentionally reducing the profitability of pharmaceutical companies. In addition, we found that pharmaceutical expenditures have been steadily and significantly increasing, although this aspect is just one of the circumstances surrounding the Japanese pharmaceutical market. On the bas...Continue Reading

References

Nov 4, 1994·Journal of Health Economics·H G Grabowski, J M Vernon
Jan 8, 2003·PharmacoEconomics·Silvia M EssThomas D Szucs
Apr 6, 2006·Health Services Research·Steven G Morgan
Aug 2, 2011·The Gerontologist·Naoko Muramatsu, Hiroko Akiyama
Jun 26, 2012·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Hideo Kurosawa, Koji Tamura
May 1, 2016·Therapeutic Innovation & Regulatory Science·Akane Takayama, Mamoru Narukawa
Jan 1, 2016·Therapeutic Innovation & Regulatory Science·Shoyo ShibataTakeshi Suzuki

❮ Previous
Next ❯

Citations

Jul 18, 2019·Therapeutic Innovation & Regulatory Science·Shoyo ShibataKoken Ozaki
Jan 1, 2017·Therapeutic Innovation & Regulatory Science·Takuma MatsudaAtsushi Aruga
Jan 1, 2017·Therapeutic Innovation & Regulatory Science·Shoyo ShibataTakeshi Suzuki
Sep 21, 2018·Therapeutic Innovation & Regulatory Science·Daigo FukumotoTakeshi Suzuki
Jun 2, 2017·Biological & Pharmaceutical Bulletin·Shoyo ShibataTakeshi Suzuki
May 2, 2018·Therapeutic Innovation & Regulatory Science·Shoyo ShibataTakeshi Suzuki

❮ Previous
Next ❯

Software Mentioned

VBM

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved